-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
-
Summary
-
Tengjun Biotechnology Corp. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q3 2010 to Q2 2023.
- Tengjun Biotechnology Corp. Earnings Per Share, Diluted for the quarter ending June 30, 2023 was 0 USD/shares, a 100% decline year-over-year.
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)